Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.



Dissertation Awards

2015 (Cycle 24)
Tobacco sensitive regulation of pro-osteogenic promoters 2015 (Cycle 24) $63,150
University of California, Riverside Early Diagnosis/Pathogenesis

Genomic approaches to identify SCLC biomarkers 2015 (Cycle 24) $63,364
Stanford University Early Diagnosis/Pathogenesis

The Impact of Trade Agreements on Domestic Health Regulation 2015 (Cycle 24) $30,000
University of California, Santa Cruz Industry Influence/Policy

Predictors of Tobacco Use in Hispanic Americans 2015 (Cycle 24) $7,090
San Diego State University Research Foundation Industry Influence/Policy

2014 (Cycle 23)
Adolescent social networks, smoking, and loneliness 2014 (Cycle 23) $60,303
University of Southern California Disparities /Prevention/ Cessation/ Nicotine Dependence

THS exposure results in Insulin Resistance 2014 (Cycle 23) $57,053
University of California, Riverside Environmental Exposure/Toxicology

Evaluation of Metal Emissions in Electronic Cigarettes 2014 (Cycle 23) $63,191
University of California, Riverside Regulatory Science/New Products

Hookah, Vascular and Endothelial Function in Humans 2014 (Cycle 23) $48,401
University of California, Los Angeles Early Diagnosis/Pathogenesis

2013 (Cycle 22)
Lynx1 modulation of alpha6 nicotinic receptors 2013 (Cycle 22) $34,560
California Institute of Technology Disparities /Prevention/ Cessation/ Nicotine Dependence

VIRTUALLY SMOKING: HOW ADOLESCENTS PERCEIVE SMOKING IMAGERY 2013 (Cycle 22) $64,800
University of California, San Francisco Disparities /Prevention/ Cessation/ Nicotine Dependence

Toxicological Evaluation of Thirdhand Smoke 2013 (Cycle 22) $60,000
University of California, Riverside Environmental Exposure/Toxicology

Cell Motility in Pulmonary Premalignancy 2013 (Cycle 22) $64,762
University of California, Los Angeles Early Diagnosis/Pathogenesis

2012 (Cycle 21)
Signaling pathways in tobacco-induced vascular dysfunction 2012 (Cycle 21) $59,500
University of California, San Diego Early Diagnosis/Pathogenesis

Lung cancer initiation by inflammatory proteins 2012 (Cycle 21) $21,207
University of California, Los Angeles Early Diagnosis/Pathogenesis

Built Environment and Tobacco Use in Homeless Shelters 2012 (Cycle 21) $59,781
University of California, Los Angeles Disparities /Prevention/ Cessation/ Nicotine Dependence

2011 (Cycle 20)
Smoking and Post-traumatic Growth Among High Risk Youth 2011 (Cycle 20) $57,392
University of Southern California Tobacco-Use Prevention and Cessation

A Novel Anti-Cancer Therapy: Inhibition of MUS81-EME1 2011 (Cycle 20) $60,000
University of California, Davis Cancer

Predicting bone teratogenicity of tobacco products in vitro 2011 (Cycle 20) $59,825
University of California, Riverside General Biomedical Science

Study of TSNA Signaling Pathway by Targeted Proteomics 2011 (Cycle 20) $60,000
University of California, Riverside General Biomedical Science

De-silencing hypermethylated tumor supressor genes 2011 (Cycle 20) $60,000
California Institute of Technology Pulmonary Disease

2010 (Cycle 19)
Replication Studies of Minor-Groove DNA Adducts 2010 (Cycle 19) $60,000
University of California, Riverside Cancer

Syntheis of the anti-cancer norcembranoid inelegnolide 2010 (Cycle 19) $59,388
University of California, Irvine Cancer

Adoption of Tobacco Programs in California Schools 2010 (Cycle 19) $47,701
University of Southern California Public Health, Public Policy, and Economics

Notch Enhances Shear-Mediated Arteriogenesis in Cerebrum 2010 (Cycle 19) $29,982
University of California, San Francisco Cardiovascular Disease

HRQoL in Veterans with Chronic PTSD and Tobacco Dependence 2010 (Cycle 19) $59,300
Alliant International University Nicotine Dependence

In search of a complement system inhibitor targeting C5aR 2010 (Cycle 19) $60,000
University of California, Riverside General Biomedical Science

Investigating Tobacco Industry Research on Polonium-210 2010 (Cycle 19) $54,504
Stanford University Public Health, Public Policy, and Economics

2009 (Cycle 18)
Molecular therapies against small cell lung cancer 2009 (Cycle 18) $60,000
Stanford University Cancer

Inhibition of ERBB2 expression by polyamides in NSCLC 2009 (Cycle 18) $59,082
California Institute of Technology Cancer

Synthesis of Spirolide-Activators of L-type Calcium Channels 2009 (Cycle 18) $60,000
University of California, Santa Barbara Cardiovascular Disease

Histone Deacetylation and Anti-inflammatory Response of GR 2009 (Cycle 18) $59,798
University of California, Berkeley General Biomedical Science

Synthesis of Anticancer Peroxides 2009 (Cycle 18) $10,873
University of California, Irvine Pulmonary Disease

Genomic Profiles in Tobacco Related Metastatic Oral Cancer 2009 (Cycle 18) $30,000
University of California, San Francisco Cancer

Cellular Analysis of BAVM Regression in a Mouse Model 2009 (Cycle 18) $60,000
University of California, San Francisco Cardiovascular Disease

Fluorescent Probes for DNA Mismatch Detection 2009 (Cycle 18) $59,749
California Institute of Technology Cancer

Repression of c-Jun oncogene activity in lung cancer 2009 (Cycle 18) $58,874
California Institute of Technology Cancer

Reactivity of Addicted Users to Advertising Cues 2009 (Cycle 18) $30,000
University of California, Irvine Tobacco-Use Prevention and Cessation

Inflammatory mediators & lung cancer progression 2009 (Cycle 18) $59,185
University of California, Los Angeles Cancer

2008 (Cycle 17)
Regulation of Integrin Activation 2008 (Cycle 17) $59,163
University of California, San Diego Cardiovascular Disease

Chromatin Remodeling in Glucocorticoid Resistance of COPD 2008 (Cycle 17) $56,648
University of California, San Francisco Pulmonary Disease

Cigarette Smoking and Stress-Coping among Latino Youth 2008 (Cycle 17) $60,000
University of Southern California Tobacco-Use Prevention and Cessation

Grainyhead-Like Transcription factor in Airway Epithelium 2008 (Cycle 17) $60,000
University of California, Irvine Pulmonary Disease

Synthesis of the Glaciapyrroles, New Anticancer Agents 2008 (Cycle 17) $60,000
University of California, Irvine Cancer

Replication Recovery Through Recombination and Mus81-Mms4 2008 (Cycle 17) $60,000
University of California, Davis General Biomedical Science

Synthesis and Evaluation of Telomerase Inhibitors 2008 (Cycle 17) $58,359
University of California, Santa Barbara General Biomedical Science

Small molecule gene regulation in lung cancer cells 2008 (Cycle 17) $31,667
California Institute of Technology Cancer

Nicotinic Regulation of Neurogenesis in Adult Hippocampus 2008 (Cycle 17) $59,910
University of California, San Diego Nicotine Dependence

2007 (Cycle 16)
NMR studies of the LDL receptor active conformation of ApoE 2007 (Cycle 16) $54,267
University of California, Berkeley Cardiovascular Disease

Size-segregated Chemical Composition of Tobacco Smoke 2007 (Cycle 16) $16,652
University of California, Irvine General Biomedical Science

Total Synthesis of Anticancer Compounds: The Neomangicols 2007 (Cycle 16) $55,292
University of California, Berkeley General Biomedical Science

Neural mechanisms underlying nicotine as a 'gateway' drug 2007 (Cycle 16) $60,000
University of California, Irvine Nicotine Dependence

2006 (Cycle 15)
Tobacco smoke and oocyte differentiation from human ES cells 2006 (Cycle 15) $60,000
University of California, San Francisco General Biomedical Science

Synthesis and Evaluation of Anticancer Agent Celogentin C 2006 (Cycle 15) $29,500
Stanford University General Biomedical Science

Effects of nicotine on schizophrenia-like cognitive deficits 2006 (Cycle 15) $58,298
University of California, San Diego Nicotine Dependence

2005 (Cycle 14)
Inhibition of cell death in head and neck cancer cells 2005 (Cycle 14) $24,148
University of Southern California Cancer

Micro RNA and dopamine-induced dentritic protein synthesis 2005 (Cycle 14) $59,000
California Institute of Technology Nicotine Dependence

Nicotine synapse formation in the hippocampus 2005 (Cycle 14) $59,500
University of California, San Diego Nicotine Dependence

Defining mutagenesis pathways in tobacco-related cancer 2005 (Cycle 14) $58,993
Scripps Research Institute Cancer

Lung cancer treatment: The total synthesis of ineleganolide 2005 (Cycle 14) $59,700
California Institute of Technology General Biomedical Science

A novel total synthesis of brazilin and brazilide A 2005 (Cycle 14) $59,191
University of California, Santa Barbara General Biomedical Science

Cell adhesion at nicotinic synapses 2005 (Cycle 14) $59,454
University of California, San Diego Nicotine Dependence

Effects of side stream tobacco smoke on DNA deletions 2005 (Cycle 14) $58,876
University of California, Los Angeles Cancer

2004 (Cycle 13)
Transcription factor modification: A role in lung cancer?" 2004 (Cycle 13) $6,097
California Institute of Technology Cancer

Smoking, atherosclerosis and MCSF gene variations 2004 (Cycle 13) $57,480
University of Southern California Cardiovascular Disease

Total synthesis of the clinical anticancer drug etoposide 2004 (Cycle 13) $59,900
California Institute of Technology General Biomedical Science

Cognitive effects of gestational nicotine 2004 (Cycle 13) $60,000
University of California, Irvine General Biomedical Science

2003 (Cycle 12)
New methods for searching tobacco industry documents 2003 (Cycle 12) $59,551
University of California, San Francisco Public Health, Public Policy, and Economics

Latino and Asian American college students' smoking 2003 (Cycle 12) $59,500
University of California, Riverside Epidemiology

Quantification of toxicants in harm reduction cigarettes 2003 (Cycle 12) $25,390
University of California, Riverside General Biomedical Science

Role of regulation orientation on framing antismoking ads 2003 (Cycle 12) $60,000
University of California, Irvine Public Health, Public Policy, and Economics

Soluble homologs of the nicotinic receptor 2003 (Cycle 12) $52,858
University of California, San Diego Nicotine Dependence

Implementation of tobacco prevention programming and smoking 2003 (Cycle 12) $58,557
University of Southern California Epidemiology

2002 (Cycle 11)
(-) Lobeline: total synthesis and derivitization 2002 (Cycle 11) $60,000
California Institute of Technology General Biomedical Science

Total Synthesis of Mitomycin C, an Anti-Cancer Therapeutic 2002 (Cycle 11) $59,947
California Institute of Technology Cancer

Cigarette smoke, MCP-1 expression in vivo and atherogenesis 2002 (Cycle 11) $50,418
University of California, Riverside Cardiovascular Disease

The determinants of college smoking 2002 (Cycle 11) $48,782
University of Southern California Epidemiology

Smoking, metabolic syndrome and subclinical atherosclerosis 2002 (Cycle 11) $23,772
University of Southern California Epidemiology

Effective diffusion of evidence-based tobacco curricula 2002 (Cycle 11) $47,747
University of Southern California Public Health, Public Policy, and Economics

2001 (Cycle 10)
Exploring transdisciplinary scientific collaboration 2001 (Cycle 10) $29,040
University of California, Irvine Public Health, Public Policy, and Economics

The effect of depression and peer influences on smoking init 2001 (Cycle 10) $53,300
University of Southern California Epidemiology

Long-term adherence after pulmonary rehabilitation for COPD 2001 (Cycle 10) $56,118
University of California, San Diego Pulmonary Disease

Effects of nicotine on taste processing 2001 (Cycle 10) $24,834
University of California, Davis Nicotine Dependence

2000 (Cycle 9)
Nicotine regulation of the noradrenergic system 2000 (Cycle 9) $52,375
University of California, Irvine Nicotine Dependence

Relationships between smoking, homocysteine & folate 2000 (Cycle 9) $48,651
University of California, San Diego Epidemiology

Patterns & risk factors for adolescent smoking progression 2000 (Cycle 9) $47,521
University of Southern California Epidemiology

Emotional intelligence and smoking across ethnicity 2000 (Cycle 9) $52,392
University of Southern California Epidemiology

Smoking in Asian youth: effect of self-image and family 2000 (Cycle 9) $60,000
California School of Professional Psychology Epidemiology

Mechanism of apparent long-term nicotinic inactivation 2000 (Cycle 9) $20,565
University of California, Riverside Nicotine Dependence

Impact of nicotinic signaling on neuronal gene expression 2000 (Cycle 9) $30,055
University of California, San Diego Nicotine Dependence

Effect of estrogen on ETS-induced glyco-oxidation 2000 (Cycle 9) $24,692
University of California, Davis Cardiovascular Disease

Heat shock proteins as biomarkers of lung oxidant stress 2000 (Cycle 9) $24,338
University of California, Davis Pulmonary Disease

1999 (Cycle 8)
Nicotinic modulation of dopamine release during development 1999 (Cycle 8) $25,698
University of California, Irvine Nicotine Dependence

Methyl-DNA Binding Protein Regulation and Function 1999 (Cycle 8) $54,546
University of California, San Diego General Biomedical Science

Effects of Nicotine on Brain Development 1999 (Cycle 8) $55,404
Cedars-Sinai Medical Center Nicotine Dependence

Environmental tobacco smoke effects on lung surfactant 1999 (Cycle 8) $47,656
University of California, Santa Barbara Pulmonary Disease

Parental and Movie Influences on Adolescent Smoking Behavior 1999 (Cycle 8) $50,793
University of California, San Diego Tobacco-Use Prevention and Cessation

Pregnancy complications and chemokine expression in smokers 1999 (Cycle 8) $24,543
University of California, San Francisco General Biomedical Science

Tobacco, Bacteria-Binding and Ca Signaling in Lung Epithelia 1999 (Cycle 8) $49,426
University of California, Berkeley Pulmonary Disease

An RNA biomarker for tobacco smoke toxicity 1999 (Cycle 8) $51,751
University of California, Davis General Biomedical Science

Modeling the relation of smoking to the ovarian function 1999 (Cycle 8) $53,448
University of California, Davis Epidemiology

Media and smoking among adolescent girls across ethnicity 1999 (Cycle 8) $53,987
University of Southern California Public Health, Public Policy, and Economics